MB
Mohit Bansal Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
41
Avg Return
Past Year
Past Year
6.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
55.6%
Neutral
44.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Maintained
| $5 |
11%
upside
| 2 | – |
–
| 5 Jan ‘26 13 days ago |
|
|
|
Overweight
Maintained
| $8 |
290%
upside
| 1 | +12% |
0
%
| 16 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $1,200 |
16%
upside
| 1 | +8.8% |
0
%
| 10 Dec ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $55 |
0%
downside
| 1 | – |
–
| 10 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $515 |
17%
upside
| 1 | +8.8% |
0
%
| 10 Dec ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $745 |
2%
upside
| 3 | +6.4% |
0
%
| 10 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $150 |
20%
upside
| 2 | +7% |
0
%
| 10 Dec ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $190 |
16%
upside
| 1 | – |
–
| 10 Dec ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $325 |
2%
downside
| 2 | +5.8% |
0
%
| 10 Dec ‘25 1 month ago |
|
|
|
Overweight
Upgraded
| $125 |
15%
upside
| 1 | +11% |
0
%
| 24 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $235 |
39%
upside
| 1 | +13% |
0
%
| 18 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $55 |
68%
upside
| 1 | -5.5% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $70 |
28%
upside
| 1 | +3.6% |
0
%
| 28 Oct ‘25 2 months ago |
|